The North America Digital Health For Cardiovascular Market is expected to witness market growth of 21.3% CAGR during the forecast period (2024-2031).
The US market dominated the North America Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $41.70 billion by 2031. The Canada market is experiencing a CAGR of 23.9% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 22.8% during 2024-2031.
Digital health for cardiovascular care refers to using advanced digital technologies, tools, and platforms to prevent, diagnose, monitor, and manage cardiovascular diseases (CVDs). Cardiovascular diseases, such as heart failure, hypertension, stroke, arrhythmias, and coronary artery disease, are among the most prevalent causes of morbidity and mortality.
Over the past decade, technological advancements and the increasing adoption of smart devices have driven the proliferation of digital health solutions. Real-time monitoring of critical cardiovascular health indicators, including heart rate, blood pressure, blood oxygen saturation, and electrocardiograms (ECG), has been enabled by wearable technologies such as smartwatches, fitness devices, and mobile ECG monitors.
The United States, Canada, and Mexico have been actively advancing digital transformation in cardiovascular healthcare through the widespread adoption of Electronic Health Records (EHRs), Health Information Exchanges (HIEs), and Cardiovascular Information Systems (CVIS). Similarly, in Canada, cardiovascular diseases continue to be a major public health concern. According to Statistics Canada, in 2023, 623 individuals were diagnosed with chronic rheumatic heart diseases, while 34,415 people had ischemic heart diseases. Cardiovascular diseases have become a major public health concern in Mexico, representing the leading cause of death in the country. In response to this growing crisis, the Mexican government has launched national strategies aimed at preventing and controlling CVDs. The National Strategy for the Prevention and Control of Overweight, Obesity, and Diabetes, implemented in 2013, focuses on public health interventions to promote healthier eating habits and physical activity. Along with government initiatives and technological advancements, these factors continue to drive the adoption of digital health solutions in cardiovascular care, making them an essential component of modern healthcare infrastructure across North America.
The US market dominated the North America Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $41.70 billion by 2031. The Canada market is experiencing a CAGR of 23.9% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 22.8% during 2024-2031.
Digital health for cardiovascular care refers to using advanced digital technologies, tools, and platforms to prevent, diagnose, monitor, and manage cardiovascular diseases (CVDs). Cardiovascular diseases, such as heart failure, hypertension, stroke, arrhythmias, and coronary artery disease, are among the most prevalent causes of morbidity and mortality.
Over the past decade, technological advancements and the increasing adoption of smart devices have driven the proliferation of digital health solutions. Real-time monitoring of critical cardiovascular health indicators, including heart rate, blood pressure, blood oxygen saturation, and electrocardiograms (ECG), has been enabled by wearable technologies such as smartwatches, fitness devices, and mobile ECG monitors.
The United States, Canada, and Mexico have been actively advancing digital transformation in cardiovascular healthcare through the widespread adoption of Electronic Health Records (EHRs), Health Information Exchanges (HIEs), and Cardiovascular Information Systems (CVIS). Similarly, in Canada, cardiovascular diseases continue to be a major public health concern. According to Statistics Canada, in 2023, 623 individuals were diagnosed with chronic rheumatic heart diseases, while 34,415 people had ischemic heart diseases. Cardiovascular diseases have become a major public health concern in Mexico, representing the leading cause of death in the country. In response to this growing crisis, the Mexican government has launched national strategies aimed at preventing and controlling CVDs. The National Strategy for the Prevention and Control of Overweight, Obesity, and Diabetes, implemented in 2013, focuses on public health interventions to promote healthier eating habits and physical activity. Along with government initiatives and technological advancements, these factors continue to drive the adoption of digital health solutions in cardiovascular care, making them an essential component of modern healthcare infrastructure across North America.
List of Key Companies Profiled
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Market Report Segmentation
By Component
- Services
- Software
- Hardware
By End-use
- Patients
- Providers
- Payers
- Other End-use
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Digital Health For Cardiovascular Market by Component
Chapter 6. North America Digital Health For Cardiovascular Market by End-use
Chapter 7. North America Digital Health For Cardiovascular Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Methodology
LOADING...
